Cobra Biologics appointed John Birch, Ph.D., to its board...Synthetic Biologics added Andrew Bristol, Ph.D., as vp of R&D and promoted Michael Kaleko, M.D., Ph.D., to svp of R&D...ViaCyte appointed Steve Altman to its board of directors...PuraMed BioScience hired Richard J. Berman as investment consultant to its management team...Amedica named Jay M. Moyes to its board of directors.
BioNTech added Sean Marett as COO...Brett A. Premack, Ph.D., joined Celtaxsys as chief technology officer...Aratana Therapeutics appointed Robert Gerber to its board of directors...Nimbus Discovery named Daniel S. Lynch executive chairman...Aegis Sciences hired Frank Moser as president...PTC Therapeutics appointed Geoffrey McDonough, M.D., to its board of directors.
AmerisourceBergen added Lawrence C. Marsh as CSO and svp, new market development...Stuart Nelson, M.D., joined Apelon as chief innovation officer...Advanced Clinical appointed Melissa Lamb to its board of trustees for the Society for Clinical Data Management...Pharmanest appointed Alan Raffensperger as chairman of its board...Tony Hill is now CEO at HiberGene Diagnostics.
Aastrom Biosciences named Joyce L. Frey-Vasconcells, Ph.D., to its scientific advisory board...Fedora Pharmaceuticals appointed Leonard E. Post, Ph.D., and Ronald W. Odynski to its board of directors...Microsaic Systems hired Colin Jump as CEO...AusBiotech appointed Michelle Burke to its board of directors...Mammen P. Mammen, Jr., M.D., joined Vical as vp, clinical vaccines.
Heptares Therapeutics appointed Roger M. Perlmutter, M.D., Ph.D., to its board of directors...Invisible Sentinel named Paul Touhey to its board of directors...sBioMed added Stephen P. MacMillan as CEO...George G. Montgomery is now CFO at Coherus BioSciences...Ocular Therapeutix appointed Richard Lindstrom, M.D., to its board of directors.
Eric W. Smart is now president and CEO of Coldstream Laboratories...Avita named Jeremy Curnock Cook and Matt McNamara to its board...Egenix appointed Rainer Fuchs, Ph.D., to its board of directors...Ortho Kinematics added Paul Gunnoe as CEO and Chip Wade, Ph.D., as chief scientist.